Riskpilot← Back to searchSign inGet full accessSignum Life Science ApS
APSActiveCVR 36559241Lersø Parkallé 101Computer consultancy and computer facilities management activities · NACE 6220Est. 201561 employees
Revenue 2024
DKK -1,9M
-226% vs 2023
EBITDA margin
474.1%
-57% vs 2023
Equity ratio
85.0%
Financial strength
Net profit 2024
DKK -5,9M
-92% vs 2023
| Revenue | DKK -1,9M | -226% |
| EBITDA | DKK -8,8M | -57% |
| Net profit | DKK -5,9M | -92% |
| Total assets | DKK 125,6M | -4% |
| Equity | DKK 106,8M | -5% |
| Employees | 61 | — |
Legal name
Signum Life Science ApS
CVR number
36559241
Legal form
Anpartsselskab
NACE code
6220 · Computer consultancy and computer facilities management activities
Founded
2. marts 2015
Share capital
DKK 75.000
Employees
61 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den samlede bestyrelse eller af bestyrelsens formand i forening med et bestyrelsesmedlem eller en direktør.
Company purpose
Selskabets formål er at drive virksomhed med salg af lægemiddelinformation og hermed beslægtet virksomhed.
Address
Lersø Parkallé 101
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 8.100 | 7.602 | -184 | 1.482 | -1.866 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 1.356 | 941 | -7.091 | -5.640 | -8.847 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 |
| EBIT | 1.356 | 941 | -7.091 | -5.640 | -8.847 |
| Net financials | 1.085 | 1.846 | -6.311 | 2.787 | 2.343 |
| Profit before tax | 2.441 | 2.787 | -13.403 | -2.853 | -6.503 |
| Tax | 1.394 | 1.470 | -2.089 | 231 | -566 |
| Net profit | 1.046 | 1.317 | -11.313 | -3.084 | -5.937 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 157.992 | 150.970 | 133.491 | 131.454 | 125.590 |
| Equity | 128.192 | 128.463 | 115.832 | 112.748 | 106.811 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 21.736 | 15.232 | 12.168 | 13.415 | 14.028 |
| Total debt | 21.736 | 15.232 | 12.168 | 13.415 | 14.028 |
EBITDA margin
-884679600.0%
This company
15.8%
Market median
-5599238075% vs market
20202024
Equity ratio
85.0%
This company
38.2%
Market median
+123% vs market
20202024
Return on equity
-5.6%
This company
18.4%
Market median
-130% vs market
20202024
Net profit margin
-593698200.0%
This company
8.1%
Market median
-7329607507% vs market
20202024
Asset turnover
-0.01×
This company
1.12×
Market median
-101% vs market
20202024
Debt / equity
0.18×
This company
0.62×
Market median
+71% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
TS Chief Executive Officer | Chief Executive Officer | 2026 |
AC | Deputy | 2024 |
| Former (4) | ||
FN | Deputy | 2024 – 2026 |
HV Chief Executive Officer | Chief Executive Officer | 2025 – 2026 |
JF Deputy | Deputy | 2016 – 2017 |
IS Chief Executive Officer | Chief Executive Officer | 2015 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (6) | ||
| Board of Directors | 2024 | |
| Deputy Chairman | 2026 | |
| Board of Directors | 2023 | |
| Board of Directors | 2024 | |
| Chairman | 2026 | |
| Board of Directors | 2026 | |
| Former (21) | ||
| Chairman | 2015 – 2016 | |
| Board of Directors | 2016 – 2017 | |
| Chairman | 2020 – 2025 | |
| Board of Directors | 2016 – 2018 | |
| Board of Directors | 2017 – 2018 | |
| Board of Directors | 2024 – 2026 | |
| Board of Directors | 2015 – 2024 | |
| Chairman | 2016 – 2017 | |
| Board of Directors | 2020 – 2022 | |
| Deputy Chairman | 2015 – 2017 | |
| Deputy Chairman | 2020 – 2021 | |
| Chairman | 2019 – 2019 | |
| Deputy Chairman | 2017 – 2018 | |
| Deputy Chairman | 2018 – 2019 | |
| Chairman | 2025 – 2026 | |
| Board of Directors | 2015 – 2016 | |
| Chairman | 2018 – 2019 | |
| Board of Directors | 2022 – 2023 | |
| Board of Directors | 2019 – 2024 | |
| Board of Directors | 2020 – 2020 | |
| Chairman | 2019 – 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 90–99.99% | 90–99.99% | 2015 | |
| Company | 10–14.99% | 0% | 2015 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
LIF LÆGEMIDDELINDUSTRIFORENINGENDLI - DANSK LÆGEMIDDEL INFORMATION A/S
Signum Life Science ApS (this company)Board members of Signum Life Science ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Felicia Nina Ida Salicath | Deputy | 0 companies |
| Henrik Vestergaard | Chief Executive Officer | 0 companies |
| Thomas Senderovitz | Chief Executive Officer | 0 companies |
| Anne Cathrine Falch-Jørgensen | Deputy | 0 companies |
| Jan Fritzbøger | Deputy | 0 companies |
| Ida Sofie Jensen | Chief Executive Officer | 0 companies |
| Jan Ulrik Stevnsborg | Chairman | 0 companies |
| Anne Marie Hedegaard Byskov | Board of Directors | 0 companies |
| Mads Tang Dalsgaard | Board of Directors | 0 companies |
| Thomas Bo Bjørn Klee | Chairman | 0 companies |
| Carina Schaldemose Sørensen | Board of Directors | 0 companies |
| Anders Thelborg | Board of Directors | 0 companies |
| Christian Bruun-Andersen | Board of Directors | 0 companies |
| Pia Krogsgaard Villadsen | Board of Directors | 0 companies |
| Christophe Duret | Chairman | 0 companies |
| Allan Karne Levisen | Board of Directors | 0 companies |
| Lasse Richter Petersen | Deputy Chairman | 0 companies |
| Mari-Ann Retz | Deputy Chairman | 0 companies |
| Andreas Daugaard Jørgensen | Deputy Chairman | 0 companies |
| Tore von Würden Petersen | Board of Directors | 0 companies |
| Mads Veggerby Lausten | Chairman | 0 companies |
| Henriette Rosenquist | Deputy Chairman | 0 companies |
| Søren Hvidsten Nielsen | Board of Directors | 0 companies |
| Anja Cecilie Verhaug | Chairman | 0 companies |
| Johannes Michael Leuchs | Board of Directors | 0 companies |
| Christina Dyreborg Jeppesen | Deputy Chairman | 0 companies |
| Julie Enevold Brooker | Chairman | 0 companies |
| Lone Henriette Andreasen | Board of Directors | 0 companies |
| Christoffer Dahl | Chairman | 0 companies |
| Jonas Emil Steenvinkel | Board of Directors | 0 companies |
| Thomas Gross Nødvig | Board of Directors | 0 companies |
| Cecilie Betzer | Board of Directors | 0 companies |
| Lars Møller | Chairman | 0 companies |